Beyond DBNPA: Future-Proof Biofilm Control with In-Situ HOCl
As 2,2-dibromo-2-cyanoacetamide (DBNPA) faces stricter European regulations due to its classification as an endocrine disruptor, industries are searching for safer, future-proof disinfection methods. The phase-out of DBNPA in applications like food industry surface treatment and general installations has created a need for alternatives that offer both high efficacy and legal certainty. In-situ generated hypochlorous acid (HOCl) has emerged as a premier solution, providing powerful microbiological control without the risks associated with hazardous chemical storage or endocrine disruption.
By utilizing on-site electrolysis of water and pure salt, the Watter system allows companies to maintain stable, high-quality production processes while effectively eliminating bacteria, viruses, and stubborn biofilms. This sustainable approach not only meets current safety standards but is also designed to withstand future legislative tightening. Early adopters have already reported crystal-clear water and microbial counts that remain consistently below internal standards, proving that transitioning away from DBNPA can actually enhance operational quality and environmental responsibility.